These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26137028)

  • 1. Vav3 oncogene is upregulated and a poor prognostic factor in breast cancer patients.
    Chen X; Chen SI; Liu XA; Zhou WB; Ma RR; Chen L
    Oncol Lett; 2015 May; 9(5):2143-2148. PubMed ID: 26137028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Vav3 protein and its prognostic value in patients with gastric cancer.
    Tan B; Li Y; Shi X; Fan L; Zhao Q; Liu Y; Tan M; Liu Q; Jia N
    Pathol Res Pract; 2017 May; 213(5):435-440. PubMed ID: 28285969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
    Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
    BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of increased guanine nucleotide exchange factor Vav3 expression in human gastric cancer.
    Lin KY; Wang LH; Hseu YC; Fang CL; Yang HL; Kumar KJ; Tai C; Uen YH
    Mol Cancer Res; 2012 Jun; 10(6):750-9. PubMed ID: 22544459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
    Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
    Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Vav3.1 as prognostic marker in endometrial cancer.
    Boesch M; Sopper S; Marth C; Fiegl H; Wiedemair A; Rössler J; Hatina J; Wolf D; Reimer D; Zeimet AG
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2067-2076. PubMed ID: 30083818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients.
    Kwon AY; Kim GI; Jeong JY; Song JY; Kwack KB; Lee C; Kang HY; Kim TH; Heo JH; An HJ
    Stem Cells Dev; 2015 Jul; 24(13):1521-35. PubMed ID: 25715123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer.
    Xiao M; Li H; Yang S; Huang Y; Jia S; Wang H; Wang J; Li Z
    J Surg Oncol; 2013 Apr; 107(5):456-62. PubMed ID: 22996179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.
    Reimer D; Boesch M; Wolf D; Marth C; Sopper S; Hatina J; Altevogt P; Parson W; Hackl H; Zeimet AG
    Int J Cancer; 2018 Apr; 142(8):1640-1651. PubMed ID: 29194596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAV3 oncogene expression in colorectal cancer: clinical aspects and functional characterization.
    Uen YH; Fang CL; Hseu YC; Shen PC; Yang HL; Wen KS; Hung ST; Wang LH; Lin KY
    Sci Rep; 2015 Mar; 5():9360. PubMed ID: 25791293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide.
    Sun W; Li C; Liu M; Liu W; Yang C; Cai LI
    Oncol Lett; 2016 Mar; 11(3):2320-2326. PubMed ID: 26998170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Breast Cancer Res Treat; 2002 Jan; 71(1):67-75. PubMed ID: 11859875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
    Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
    Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
    Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
    Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.